Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01637415 · ClinicalTrials.gov registry record
The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 409
- Enrollment target
NCT01637415: Completed study, sponsored by Stanford University.
NCT01637415 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 409 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01637415 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 409 participants
- Enrollment target
Study Summary
Although there are several tools that can be used to evaluate the severity of ongoing alcohol withdrawal syndrome (AWS), there is no available tool that can predict which patients are at risk for developing AWS at the time admission, before the patient has developed AWS. Unfortunately, there are severe symptoms of alcohol withdrawal (e.g., seizures) which may develop early in the hospitalization, and before the development of other systemic symptoms which may warn medical personnel of the possibility of impeding alcohol withdrawal (e.g., autonomic instability, delirium). The goal of this study is to evaluate the psychometric properties (e.g., predictive validity) of a new tool, the Prediction of Alcohol Withdrawal Severity Scale (PAWSS), on identifying which patients are at risk for developing complicated AWS (i.e., seizures, hallucinosis, delirium tremens) among hospitalized, medically ill patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01637415
The ClinicalTrials.gov registry entry for NCT01637415 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01637415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01637415 about?
NCT01637415 is a clinical study titled "The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)". Although there are several tools that can be used to evaluate the severity of ongoing alcohol withdrawal syndrome (AWS), there is no available tool that can predict which patients are at risk for developing AWS at the time admission, before the patient has developed AWS. Unfortunately, there are sev...
What is the current status of trial NCT01637415?
This trial is currently completed. The enrollment target is 409 participants. The study started on 2012-05. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01637415?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.